PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement

Value in Health- United Kingdom

doi 10.1016/j.jval.2012.08.1383

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV


Related search